It has been demonstrated that individuals with FHH are heterozygous, and children within these families with severe neonatal primary hyperparathyroidism (NSHPT) are homozygous for CASR mutations (Janicic et al. 1995; Pollak et al. 1993). This evidence concerns the gene CASR and familial hypocalciuric hypercalcemia.